-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Ankylosing Spondylitis Clinical Trial Analysis Report Overview A total of 1,072 Ankylosing Spondylitis clinical trials were conducted as of January 2024. The Ankylosing Spondylitis clinical trial report provides a comprehensive understanding of the Ankylosing Spondylitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       ...
-
Product Insights
Psoriatic Arthritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Psoriatic Arthritis - Drugs In Development, 2023’, provides an overview of the Psoriatic Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Drugs In Development, 2023’, provides an overview of the Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Juvenile Arthritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Juvenile Arthritis - Drugs In Development, 2023’, provides an overview of the Juvenile Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Juvenile Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Axial Spondyloarthritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Axial Spondyloarthritis - Drugs In Development, 2023’, provides an overview of the Axial Spondyloarthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Drugs In Development, 2023’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Polyarticular Juvenile Idiopathic Arthritis (PJIA) – Drugs In Development, 2023
Global Markets Direct’s, ‘Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Drugs In Development, 2023’, provides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polyarticular Juvenile Idiopathic Arthritis (PJIA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Sector Analysis
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Report Overview PsA is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and the sacroiliac joints of the pelvis. Clinical diagnosis and assessment of PsA involve a combination of patient history, physical examination, laboratory tests, and imaging studies. The goal of diagnosis and assessment is to identify the presence and extent of joint involvement, assess...
-
Sector Analysis
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2031
Osteoarthritis Market Overview The osteoarthritis market size was valued at $2.5 billion in 2021 and is expected to achieve a CAGR of more than 4% during 2021-2031. OA is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. Contrary to the previous notion that OA is exclusively a disorder of articular cartilage, studies have demonstrated it is a disease of the whole joint, adversely affecting the subchondral bone,...
-
Sector Analysis
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
Osteoarthritis (OA) market size was 18,820,737 cases in 2021 cases across 7MM. The market is expected to grow at an AGR of more than 1% during the forecast period. The osteoarthritis epidemiology market research report provides an overview of the risk factors, comorbidities, and global and historical trends for hand OA, knee OA, and hip OA in the seven major markets or 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total...